by Ethan Roberson | May 11, 2022 | Press Release
● ArisGlobal announces acquisition of Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment ● As a part of the LifeSphere® platform, this solution will...
by Ethan Roberson | May 6, 2022 | Press Release
Life sciences technology leader welcomes five executives to elevate the organization across the business, information security, and compliance sectors. MIAMI, FL — April 26— ArisGlobal, the leading provider of life sciences software that automates core drug...
by Ethan Roberson | May 2, 2022 | Press Release
LifeSphere Clinical continues to make a substantial industry impact providing actionable thought leadership at clinical events nationwide. NEW ORLEANS, May 2 – ArisGlobal®, the leading provider of life sciences software that automates core drug development...
by Ethan Roberson | Apr 5, 2022 | Press Release
ArisGlobal’s LifeSphere sees significant uptake of clinical software adoption in key clinical trial markets worldwide. MIAMI, FL – ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end...
by Ethan Roberson | Apr 1, 2022 | Press Release
In person attendance, speaking session, and LifeSphere Regulatory demos mark the life sciences software leader’s return to the convention circuit. MIAMI, April 1 – ArisGlobal®, the leading provider of life sciences software that automates core drug development...
by Ethan Roberson | Mar 22, 2022 | Press Release
MIAMI, FL – March 18, 2022 – ArisGlobal®, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces its virtual participation in DIA’s Medical Affairs...
Recent Comments